BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 19397903)

  • 1. Decreased ratio of high-molecular-weight to total adiponectin is associated with angiographic coronary atherosclerosis severity but not restenosis.
    Liang KW; Lee WJ; Lee WL; Ting CT; Sheu WH
    Clin Chim Acta; 2009 Jul; 405(1-2):114-8. PubMed ID: 19397903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective, randomized, single-blind comparison of effects of 6 months of treatment with telmisartan versus enalapril on high-molecular-weight adiponectin concentrations in patients with coronary artery disease.
    Satoh M; Tabuchi T; Minami Y; Takahashi Y; Itoh T; Nakamura M
    Clin Ther; 2009 Oct; 31(10):2113-25. PubMed ID: 19922882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High molecular weight adiponectin as a predictor of long-term clinical outcome in patients with coronary artery disease.
    Inoue T; Kotooka N; Morooka T; Komoda H; Uchida T; Aso Y; Inukai T; Okuno T; Node K
    Am J Cardiol; 2007 Aug; 100(4):569-74. PubMed ID: 17697807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total and high molecular weight adiponectin in patients with coronary artery disease.
    El-Menyar A; Rizk N; Al Nabti AD; Hassira SA; Singh R; Abdel Rahman MO; Suwaidi JA
    J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):310-5. PubMed ID: 19430341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of the circulating adiponectin concentration with coronary in-stent restenosis in haemodialysis patients.
    Nishimura M; Hashimoto T; Kobayashi H; Yamazaki S; Okino K; Fujita H; Inoue N; Takahashi H; Ono T
    Nephrol Dial Transplant; 2006 Jun; 21(6):1640-7. PubMed ID: 16431887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adiponectin isoforms are not associated with the severity of coronary atherosclerosis but with undiagnosed diabetes in patients affected by stable CAD.
    Rizza S; Clementi F; Porzio O; Cardellini M; Savo A; Serino M; Chiricolo G; Romeo F; Lauro R; Federici M
    Nutr Metab Cardiovasc Dis; 2009 Jan; 19(1):54-60. PubMed ID: 18472407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High molecular weight multimer form of adiponectin as a useful marker to evaluate insulin resistance and metabolic syndrome in Japanese men.
    Seino Y; Hirose H; Saito I; Itoh H
    Metabolism; 2007 Nov; 56(11):1493-9. PubMed ID: 17950099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of serum high-molecular weight (HMW) adiponectin with total adiponectin concentrations in type 2 diabetic patients with coronary artery disease using a novel enzyme-linked immunosorbent assay to detect HMW adiponectin.
    Aso Y; Yamamoto R; Wakabayashi S; Uchida T; Takayanagi K; Takebayashi K; Okuno T; Inoue T; Node K; Tobe T; Inukai T; Nakano Y
    Diabetes; 2006 Jul; 55(7):1954-60. PubMed ID: 16804063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The presence of metabolic syndrome is independently associated with elevated serum CD40 ligand and disease severity in patients with symptomatic coronary artery disease.
    Lee WL; Lee WJ; Chen YT; Liu TJ; Liang KW; Ting CT; Huey-Herng Sheu W
    Metabolism; 2006 Aug; 55(8):1029-34. PubMed ID: 16839837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes exacerbates angiographic coronary lesion progression in subjects with metabolic syndrome independent of CRP levels.
    Liang KW; Lee WJ; Lee WL; Chen YT; Ting CT; Sheu WH
    Clin Chim Acta; 2008 Feb; 388(1-2):41-5. PubMed ID: 17967444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel atherogenesis markers for identification of patients with a multivessel coronary artery disease.
    Krecki R; Drozdz J; Szcześniak P; Orszulak-Michalak D; Krzemińska-Pakuła M
    Kardiol Pol; 2008 Nov; 66(11):1173-80; discussion 1181-2. PubMed ID: 19105094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum high-molecular weight adiponectin decreases abruptly after an oral glucose load in subjects with normal glucose tolerance or impaired fasting glucose, but not those with impaired glucose tolerance or diabetes mellitus.
    Ozeki N; Hara K; Yatsuka C; Nakano T; Matsumoto S; Suetsugu M; Nakamachi T; Takebayashi K; Inukai T; Haruki K; Aso Y
    Metabolism; 2009 Oct; 58(10):1470-6. PubMed ID: 19592051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High sensitive C-reactive protein, adiponectin, and urine albumin excretion rate in Chinese coronary artery disease patients with different glucose tolerance status.
    Gui MH; Hong J; Lü AK; Chen Y; Shen WF; Li XY; Ning G
    Chin Med J (Engl); 2008 Dec; 121(24):2509-16. PubMed ID: 19187587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-molecular-weight adiponectin is a predictor of progression to metabolic syndrome: a population-based 6-year follow-up study in Japanese men.
    Seino Y; Hirose H; Saito I; Itoh H
    Metabolism; 2009 Mar; 58(3):355-60. PubMed ID: 19217451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low basal levels of circulating adiponectin in patients undergoing coronary stenting predict in-stent restenosis, independently of basal levels of inflammatory markers: lipoprotein associated phospholipase A2, and myeloperoxidase.
    Moldoveanu E; Mut-Vitcu B; Tanaseanu GR; Marta DS; Manea G; Kosaka T; Vidulescu C; Tanaseanu C
    Clin Biochem; 2008 Dec; 41(18):1429-33. PubMed ID: 18930040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased circulating protective adiponectin level is associated with angiographic coronary disease progression in patients with angina pectoris.
    Liang KW; Sheu WH; Lee WL; Liu TJ; Ting CT; Hsieh YC; Wang KY; Chen YT; Lee WJ
    Int J Cardiol; 2008 Sep; 129(1):76-80. PubMed ID: 17651832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of losartan on serum total and high-molecular weight adiponectin concentrations in hypertensive patients with metabolic syndrome.
    Uchida T; Shimizu M; Sakai Y; Nakano T; Hara K; Takebayashi K; Inoue T; Node K; Inukai T; Takayanagi K; Aso Y
    Metabolism; 2008 Sep; 57(9):1278-85. PubMed ID: 18702955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in adiponectin multimer distribution in response to atorvastatin treatment in patients with type 2 diabetes.
    von Eynatten M; Liu D; Bluemm A; Schuster T; Baumann M; Lutz J; Heemann U; Dugi KA; Nawroth PP; Bierhaus A; Humpert PM
    Clin Endocrinol (Oxf); 2009 Jul; 71(1):27-32. PubMed ID: 18778396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Potential of plasma adiponectin concentrations as a predictive marker for in-stent restenosis after percutaneous coronary intervention in patients on hemodialysis].
    Nishimura M; Takahashi H
    Rinsho Byori; 2011 Aug; 59(8):795-800. PubMed ID: 21942090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low serum adiponectin is independently associated with both the metabolic syndrome and angiographically determined coronary atherosclerosis.
    Saely CH; Risch L; Hoefle G; Rein P; Muendlein A; Marte T; Aczel S; Langer P; Drexel H
    Clin Chim Acta; 2007 Aug; 383(1-2):97-102. PubMed ID: 17550784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.